NIH-funded research R01 grant

How cannabis affects teen brain development and thinking

Official title: Microglia-mediated adverse effect of cannabis on prefrontal cortex maturation and cognitive function

Funded at Johns Hopkins University · NIH-11251991 · Data updated 2026-11-12

This research looks at whether THC in cannabis changes brain immune cells during adolescence and harms thinking and self-control in teens and young adults.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJanuary 1, 2025
Project endNovember 30, 2029
Funding year2026
Award (this year)$709,558
NIH project number5R01DA060630-02
Project IDNIH-11251991 on NIH RePORTER

Who could benefit from this research

Could help

The research is aimed at teenagers and young adults who used cannabis heavily during adolescence or started regular use before adulthood.

Less likely to help

People who never used cannabis during adolescence or whose cognitive problems come from other causes may not directly benefit from these findings.

What this research studies

Researchers will use laboratory models that mimic adolescent THC exposure to see how microglia (the brain’s immune cells) change in the prefrontal cortex. They will analyze molecular signals in microglia, record neuron activity, and link those changes to behavior tests for attention and impulse control. The team will use genetic mouse models that reflect human risk factors and combine cellular, molecular, and behavioral experiments to connect biology with cognitive outcomes. Results will point toward whether targeting microglia could prevent or reduce cannabis-related thinking problems.

Why it matters

Potential benefit: If successful, this work could identify biological targets to prevent or treat thinking and self-control problems linked to heavy adolescent cannabis use.

How similar studies have gone: Previous animal studies have shown microglial changes and behavioral deficits after adolescent THC exposure, but the detailed molecular pathways are largely unproven.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Kamiya, Atsushi — Johns Hopkins University
  • Study coordinator: Kamiya, Atsushi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.